Skip to content
Back to announcement

Surat Pernyataan Direksi LK TW1.pdf

Financial statement Text extracted INAF

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 1

Page 1 OCR 0.873
(/
indofarma

Member of Biofarma Group

SURAT PERNYATAAN DIREKSI DIRECTORS' STATEMENT LETTER
TENTANG TANGGUNG JAWAB ATAS REGARDING THE RESPONSIBILITY FOR
LAPORAN KEUANGAN THE FINANCIAL STATEMENIS
TANGGAL 31 MARET 2025 AS OF MARCH 31, 2025
DAN UNTUK PERIODE TIGA BULAN YANG AND FOR THE THREE-MONTH
BERAKHIR PADA TANGGAL TERSEBUT PERIOD THEN ENDED
PT INDOFARMA Tbk PT INDOFARMA Tbk
Kami yang bertanda tangan di bawah ini: We, the undersigned :

Nama : Yeliandriani : Name
Alamat Kantor : Jl. Indofarma No. 1, Cikarang Barat 17530 : Official Address
NIK : 3174034301640004 : ID Number
Jabatan 8 Direktur Utama / President Director H Position
Menyatakan bahwa : State that :

I. Kami bertanggungjawab atas penyusunan dan penyajian — 1. We are responsible for preparation and presentation of
laporan keuangan PT Indofarma Tbk: the financial statements of PT Indofarma Tbk,

2. Laporan keuangan PT Indofarma Tbk telah disusun dan 2. The financial statemenis of PT Indofarma Tbk have
disajikan sesuai dengan Standar Akuntansi Keuangan di been prepared and presented in aecordance with
Indonesia, Indonesian Financial Accounting Standards:

3. @. Semua informasi dalam laporan keuangan PT 3 4 Ay information contained in the financial

Indofarma Tbk telah dimuat secara lengkap dan statements of PT Indofarma Tbk is complete and
benar, . correct:
b. Laporan keuangan PT Indofarma Tbk tidak b. The financial statements of PT Indofarma Tbk do

mengandung informasi atau fakta material yang

1 " : P: p not contain misleading material information or
tidak benar, dan tidak menghilangkan informasi atau

facts, and do not omit material information and

fakta material, facts:
4. Kam bertanggung, jawab uas sistem pengendalian 4 Wegoreperatik for the internal control system of PT
Demikian pernyataan ini dibuat dengan sebenarnya. This statement letter is made truthfully.

Jakarta, 29 April 2025 / April 29, 2025
PT Indofarma Tbk

Direktur Utama
/ President Director

: kebawa”

Yeliandriani Pp -
PT Indofarma Tbk Ph. 62-21-88323971/75 Email: headoffice@indofarma.id
Jl. Indofarma No.1, Cikarang Barat Fx. 62-21-88323972/73 www.indofarma.id

Bekasi 17530 - Indonesia

File

File Open PDF
Source IDX
Size0.36 MB
Published14 May 2025
Pages1
Characters2,155
Text sourceOCR
OCR confidence0.873

Names mentioned 1 people and organisations named in the text · linked when the evidence is strong

possible org INDOFARMA Tbk p.1 ×23

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

No extraction attempted yet.

Other files in this announcement 6

FinancialStatement-2025-I-INAF.xlsx done
inlineXBRL.zip done
↑↓ select ↵ open ⇧↵ see every result